RU94036745A - Производные галантамина и фармацевтическая композиция - Google Patents

Производные галантамина и фармацевтическая композиция

Info

Publication number
RU94036745A
RU94036745A RU94036745/04A RU94036745A RU94036745A RU 94036745 A RU94036745 A RU 94036745A RU 94036745/04 A RU94036745/04 A RU 94036745/04A RU 94036745 A RU94036745 A RU 94036745A RU 94036745 A RU94036745 A RU 94036745A
Authority
RU
Russia
Prior art keywords
compounds
pharmaceutical composition
galantamine derivatives
galantamine
derivatives
Prior art date
Application number
RU94036745/04A
Other languages
English (en)
Other versions
RU2109743C1 (ru
Inventor
В.Кослей Раймонд (младший)
Us]
Дэвис Ларри
Таберна Вероника
Uy]
Original Assignee
Хехст-Рассел Фармасьютикалз Инкорпорейтед (US)
Хехст-Рассел Фармасьютикалз Инкорпорейтед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хехст-Рассел Фармасьютикалз Инкорпорейтед (US), Хехст-Рассел Фармасьютикалз Инкорпорейтед filed Critical Хехст-Рассел Фармасьютикалз Инкорпорейтед (US)
Publication of RU94036745A publication Critical patent/RU94036745A/ru
Application granted granted Critical
Publication of RU2109743C1 publication Critical patent/RU2109743C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

Описываются производные галантамина как ингибиторы ацетилхолинэстеразы. В частности, описываются соединения, формула и значения радикалов которой приведена в описании изобретения, для лечения нарушения памяти, характеризующегося пониженной холинэргической функцией, фармацевтические композиции, содержащие эти соединения, и способы получения и применения этих соединений.

Claims (1)

  1. Описываются производные галантамина как ингибиторы ацетилхолинэстеразы. В частности, описываются соединения, формула и значения радикалов которой приведена в описании изобретения, для лечения нарушения памяти, характеризующегося пониженной холинэргической функцией, фармацевтические композиции, содержащие эти соединения, и способы получения и применения этих соединений.
RU94036745A 1993-10-15 1994-10-13 Производные галантамина и фармацевтическая композиция RU2109743C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/137,444 US6316439B1 (en) 1993-10-15 1993-10-15 Galanthamine derivatives as acetylcholinesterase inhibitors
US08/137.444 1993-10-15

Publications (2)

Publication Number Publication Date
RU94036745A true RU94036745A (ru) 1996-12-10
RU2109743C1 RU2109743C1 (ru) 1998-04-27

Family

ID=22477461

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94036745A RU2109743C1 (ru) 1993-10-15 1994-10-13 Производные галантамина и фармацевтическая композиция

Country Status (23)

Country Link
US (1) US6316439B1 (ru)
EP (1) EP0649846B1 (ru)
JP (1) JP2664343B2 (ru)
KR (1) KR100227957B1 (ru)
CN (1) CN1039910C (ru)
AT (1) ATE211474T1 (ru)
AU (1) AU696170B2 (ru)
CA (1) CA2118172C (ru)
CZ (1) CZ283731B6 (ru)
DE (1) DE69429570T2 (ru)
DK (1) DK0649846T3 (ru)
EG (1) EG20726A (ru)
ES (1) ES2170759T3 (ru)
FI (1) FI108722B (ru)
IL (1) IL111275A (ru)
NO (1) NO307464B1 (ru)
NZ (1) NZ264682A (ru)
PL (1) PL177549B1 (ru)
PT (1) PT649846E (ru)
RO (1) RO114134B1 (ru)
RU (1) RU2109743C1 (ru)
TW (1) TW289754B (ru)
ZA (1) ZA948061B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT403803B (de) 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
EP2311463A1 (en) * 1999-12-10 2011-04-20 Bonnie M. Davis Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
JP2005503345A (ja) * 2001-04-30 2005-02-03 バイエル・コーポレーシヨン 新規な４−アミノ−５，６−置換チオフェノ［２，３−ｄ］ピリミジン
US20030162770A1 (en) * 2002-02-22 2003-08-28 Davis Bonnie M. Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
US20040254146A1 (en) * 2002-05-21 2004-12-16 Nastech Pharmaceutical Company Inc. Carboxylate salts of galantamine and their pharmaceutical use
US20050143350A1 (en) * 2003-11-19 2005-06-30 Seed John C. Combination drug therapy to treat obesity
WO2005065662A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Solid dosage formulations of galantamine
CA2551946A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galantamine
US20080045500A1 (en) * 2004-07-01 2008-02-21 Eisai R&D Management Co., Ltd. Nerve Regeneration Stimulator
EP2425845A1 (en) * 2004-12-23 2012-03-07 Voyager Pharmaceutical Corporation Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
PT1895994E (pt) * 2005-05-13 2010-12-03 Alza Corp Sistema de administração de medicamentos de camada múltipla com barreira contra o fluxo de material do reservatório
US20080188510A1 (en) * 2005-05-23 2008-08-07 Eisai R & D Management Co., Ltd. Novel methods using zonisamide
US20090253654A1 (en) 2005-09-22 2009-10-08 Galantos Pharma Gmbh Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
EP1937226A2 (en) * 2005-09-23 2008-07-02 Alza Corporation Transdermal galantamine delivery system
ES2463715T3 (es) 2008-04-14 2014-05-29 Neurodyn Life Sciences Inc. Derivados de galantamina como profármacos para el tratamiento de enfermedades del cerebro humano
CA2768668A1 (en) * 2009-07-23 2011-01-27 Shire Llc Galantamine amino acid and peptide prodrugs and uses thereof
WO2015176069A2 (en) * 2014-05-16 2015-11-19 Synaptec Development Llc CLEARANCE OF AMYLOID ß
EP4029867A1 (en) 2021-01-13 2022-07-20 Alpha Cognition Inc. Solid forms of galantamine benzoate gluconate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL122665B1 (en) 1978-11-21 1982-08-31 Edinen Zentar Chim Process for preparing novel dienones of narvedine type and their derivatives
US4663318A (en) 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
US6150354A (en) * 1987-01-15 2000-11-21 Bonnie Davis Compounds for the treatment of Alzheimer's disease
ATE411026T1 (de) * 1987-05-04 2008-10-15 Bonnie Davis Mittel zur behandlung der alzheimer-krankheit
NL8800350A (nl) 1988-02-12 1989-09-01 Stichting Biomedical Research Synthetische galanthamine-derivaten, werkwijze voor het bereiden daarvan, en farmaceutische samenstellingen.
DE69229781T2 (de) 1991-05-14 2000-01-05 Ernir Snorrason Behandlung des ermüdungssyndroms mit cholinesteraseinhibitoren
US5153193A (en) 1991-10-01 1992-10-06 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs

Also Published As

Publication number Publication date
PT649846E (pt) 2002-06-28
FI944823A (fi) 1995-04-16
CA2118172C (en) 2000-01-04
ZA948061B (en) 1995-06-06
FI108722B (fi) 2002-03-15
IL111275A (en) 2003-01-12
NZ264682A (en) 1995-07-26
KR950011445A (ko) 1995-05-15
ATE211474T1 (de) 2002-01-15
CZ283731B6 (cs) 1998-06-17
DK0649846T3 (da) 2002-04-15
RU2109743C1 (ru) 1998-04-27
US6316439B1 (en) 2001-11-13
AU7581394A (en) 1995-05-04
CA2118172A1 (en) 1995-04-16
IL111275A0 (en) 1994-12-29
EP0649846A1 (en) 1995-04-26
PL305457A1 (en) 1995-04-18
DE69429570D1 (de) 2002-02-07
JPH07188239A (ja) 1995-07-25
PL177549B1 (pl) 1999-12-31
EP0649846B1 (en) 2002-01-02
NO943895L (no) 1995-04-18
AU696170B2 (en) 1998-09-03
JP2664343B2 (ja) 1997-10-15
ES2170759T3 (es) 2002-08-16
KR100227957B1 (ko) 1999-11-01
EG20726A (en) 1999-12-29
NO943895D0 (no) 1994-10-14
CN1108657A (zh) 1995-09-20
FI944823A0 (fi) 1994-10-13
DE69429570T2 (de) 2002-08-29
CZ254594A3 (en) 1995-07-12
CN1039910C (zh) 1998-09-23
NO307464B1 (no) 2000-04-10
RO114134B1 (ro) 1999-01-29
TW289754B (ru) 1996-11-01

Similar Documents

Publication Publication Date Title
RU94036745A (ru) Производные галантамина и фармацевтическая композиция
RU94036448A (ru) Производные галантамина и фармацевтическая композиция
ATE177420T1 (de) Cyclobutan-derivate als inhibitoren der squalen- synthetase und der protein-farnesyltransferase
WO2001098277A3 (en) Substituted bicyclic derivatives for the treatment of abnormal cell growth
MX9702865A (es) Agentes estrogenicos.
RU94040859A (ru) Аминопроизводные оксо- и гидрокси-замещенных углеводородов, способы получения, фармацевтические композиции, способ ингибирования ретровирусной протеазы, способ лечения спида у млекопитающих
TR199900428T2 (xx) 1,4-Heterosiklik metaloproteaz inhibit�rleri.
RU95104885A (ru) 1h-индол-3-глиоксиламиды, ингибирующие spla2-медируемое выделение жирных кислот, фармацевтическая композиция
DE60214179D1 (de) IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN
TR199900383T2 (xx) 1,3-Diheterosiklik metaloproteaz inhibit�rleri.
IL162214A0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
RU94036761A (ru) Производные галантамина и фармацевтическая композиция
ATE232873T1 (de) Phosphonsaürederivate als ptp-1b-inhibitoren
WO1999020606A3 (en) Piperidines and piperazines as platelet aggregation inhibitors
EP0807633A3 (en) Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
BRPI0410669A (pt) inibidores de caspase e usos dos mesmo
ES2243579T3 (es) Derivados de pirazolopirideno.
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
NO984470L (no) Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
NO984740L (no) Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler
NO971625L (no) Nye peptider med immunomodulatoriske effekter
TR199700999T1 (xx) Askomisinler.

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
PC4A Invention patent assignment

Effective date: 20101102

PC41 Official registration of the transfer of exclusive right

Effective date: 20101227